Bio-Rad Laboratories Class B (BIO.B)

• Market cap: $7.01B
• 1 day: 0.00%
• 5 days: 0.00%
• 1 month: 0.00%
• 3 months: 9.96%
• 6 months: -26.14%
• Year to date: -24.41%
• 1 year: -12.40%
• 5 years: -48.10%
• 10 years: 70.45%
• Sector: Healthcare
• Industry: Medical Devices

About: Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Employees: 7,700

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.02% less ownership

Funds ownership: 0.07% [Q4 2024] → 0.04% (-0.02%) [Q1 2025]

38% less funds holding

Funds holding: 8 [Q4 2024] → 5 (-3) [Q1 2025]

52% less capital invested

Capital invested by funds: $1.08M [Q4 2024] → $518K (-$559K) [Q1 2025]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1